JANX supply chain intelligence for Janux Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| MRK | Merck & Co., Inc. | 90% | Merck has the unilateral right to terminate the agreement in its entirety or on a Collaboration Target by Collaboration Target basis at any time and for any reason upon prior written notice to us. |
| MRK | Merck & Co., Inc. | 90% | Reciprocal relationship from MRK graph: Reciprocal relationship from JANX graph: Merck has the unilateral right to terminate the agreement in its entirety or on a Collaboration Target by Collaboratio… |
| WUXI-BIOLOGICS-HONG-KONG-LIMITED | WUXI-BIOLOGICS-HONG-KONG-LIMITED | 85% | In consideration for the license, we agreed to pay WuXi Biologics a non-refundable, one-time license fee of $0.2 million upon Wuxi Biologics’ achievement of a certain technical milestone, which was a… |
| BMY | Bristol-Myers Squibb Company | 72% | Reciprocal relationship from BMY graph: Reciprocal relationship from JANX graph: ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks fo… |
| BMY | Bristol-Myers Squibb Company | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| BMYMP | Bristol-Myers Squibb Co | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| BMYMP | Bristol-Myers Squibb Co | 72% | Reciprocal relationship from BMYMP graph: Reciprocal relationship from JANX graph: ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks … |
| INAB | IN8bio, Inc. | 72% | Reciprocal relationship from INAB graph: Reciprocal relationship from JANX graph: Reciprocal relationship from INAB graph: Reciprocal relationship from JANX graph: Reciprocal relationship from INAB g… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from JANX graph: ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks fo… |
| JNJ | Johnson & Johnson | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from JANX graph: ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks … |
| SNYNF | Sanofi | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | 92% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| BMY | Bristol-Myers Squibb Company | 92% | Reciprocal relationship from BMY graph: Reciprocal relationship from JANX graph: ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks fo… |
| BMYMP | Bristol-Myers Squibb Co | 72% | Reciprocal relationship from BMYMP graph: Reciprocal relationship from JANX graph: Reciprocal relationship from BMYMP graph: Reciprocal relationship from JANX graph: Reciprocal relationship from BMYM… |
| BMYMP | Bristol-Myers Squibb Co | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| INAB | IN8bio, Inc. | 72% | Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intellectual Property.” Sales and Marketing Given our stage of development, we have not ye… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from JANX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from JANX graph: Reciprocal relationship from JNJ grap… |
| JNJ | Johnson & Johnson | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| SNYNF | Sanofi | 72% | ach master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is possib… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from JANX graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from JANX graph: Reciprocal relationship from SNYN… |
| ADAGENE-BIOATLA-CHUGAI-PHARMACEUTICAL-CO-ROCHE-H | ADAGENE-BIOATLA-CHUGAI-PHARMACEUTICAL-CO-ROCHE-H | 62% | ons. Each master cell bank is or will be stored in two independent locations, and we intend to produce working cell banks for each product candidate later in the course of product development. It is … |
| HEALTH-RESOURCES | HEALTH-RESOURCES | 62% | val by the physician’s or health care professional’s employer, their competent professional organization and/or the regulatory authorities of the individual European Union member states. Failure to c… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| JANX-DEBT | Debt stack $21.6M | 90% | Market cache reports total debt of $21.6M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| JANX-OWNER-RA-CAPITAL-MANAGEMENT-L-P | RA CAPITAL MANAGEMENT, L.P. | 90% | 13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 193 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | 100.00 | 2 | |
| BNR | Burning Rock Biotech Limited | 100.00 | 2 | |
| CYTK | Cytokinetics, Incorporated | 100.00 | 2 | |
| ALXO | ALX Oncology Holdings Inc. | 100.00 | 2 | |
| BSX | Boston Scientific Corporation | 100.00 | 2 | |
| CBIO | Crescent Biopharma, Inc. | 100.00 | 2 | |
| BLLN | BillionToOne, Inc. | 100.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 100.00 | 2 | |
| CYTOF | Altamira Therapeutics Ltd. | 100.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 100.00 | 2 | |
| ANIK | Anika Therapeutics, Inc. | 100.00 | 2 | |
| ANL | Adlai Nortye Ltd. | 100.00 | 2 | |
| WHWK | Whitehawk Therapeutics, Inc. | 100.00 | 2 | |
| ANRO | Alto Neuroscience, Inc. | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| AVBP | ArriVent BioPharma, Inc. | 100.00 | 2 | |
| BLRX | BioLineRx Ltd. | 100.00 | 2 | |
| EMMA | Emmaus Life Sciences, Inc. | 100.00 | 2 | |
| BNBX | BNB Plus Corp. | 100.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 100.00 | 2 |